Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients

European Journal of Anaesthesiology
H-J LeeK-H Kim

Abstract

The purpose of this study was to investigate the acceptability and therapeutic efficacy of a preoperative single administration of long-acting 5-hydroxytryptamine type 3 (5-HT 3) receptor antagonist in an orally disintegrating tablet formulation, ramosetron, in breast cancer patients. Two hundred and forty women, ASA I-II, aged 24-60 yr, undergoing elective breast cancer surgery, were randomized. A standardized anaesthetic technique was used. Patients were assigned to receive one of three treatment regimens (n = 80 in each group): no prophylactic antiemetics (Group A), single prophylactic intravenous injection of ramosetron 0.1 mg at the completion of surgery (Group B) or preoperatively oral administration of 0.1 mg of ramosetron (Group C). Episodes of nausea and vomiting, the use of rescue antiemetic treatment, degree of pain, adverse events and level of satisfaction were recorded. The overall incidence of nausea and vomiting during the first 24 h after the recovery in Groups B (27.8%) and C (25%) was decreased significantly compared with Group A (75.3%). The frequency of the use of rescue antiemetics was significantly lower in Group C (5.0%) compared with Groups A (53.2%) and B (15.2%). The patients in Group C were more satis...Continue Reading

References

Jan 21, 1995·BMJ : British Medical Journal·J M Bland, D G Altman
Jan 1, 1994·Anesthesia and Analgesia·M M CohenW A Tweed
Dec 23, 1998·British Journal of Anaesthesia·M DresnerM Bellamy
Dec 6, 2001·BMC Anesthesiology·Faranak Kazemi-KjellbergMartin R Tramèr
Aug 9, 2002·The Journal of International Medical Research·K NodaM Nakashima
Apr 18, 2003·The European Journal of Surgery = Acta Chirurgica·Yoshitaka FujiiHiroyoshi Tanaka
Jun 26, 2004·Journal of Clinical Anesthesia·Kevin P BauerJennifer E O'Flaherty
Jan 22, 2005·Critical Reviews in Therapeutic Drug Carrier Systems·Yourong FuKinam Park
Feb 27, 2007·Inflammopharmacology·I Hirata, M Murano
Mar 23, 2007·Anesthesia and Analgesia·Michael J PaechDorota A Doherty
May 24, 2007·Der Anaesthesist·M R Tramèr
Jul 27, 2007·Journal of Pharmacological Sciences·Takuya HirataMasao Sasamata

❮ Previous
Next ❯

Citations

Sep 3, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Carlo PirriPeter Drummond
Aug 7, 2012·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hiroyuki Tsutsumi
Nov 26, 2010·The British Journal of Surgery·R Arsalani-ZadehJ MacFie
Dec 21, 2013·Anesthesia and Analgesia·Tong J GanUNKNOWN Society for Ambulatory Anesthesia
Dec 8, 2011·Korean journal of anesthesiology·Won Oak KimHae Keum Kil
Oct 20, 2020·The Cochrane Database of Systematic Reviews·Stephanie WeibelPeter Kranke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

Chemical Society Reviews
Yiding LiuYadong Yin
Dalton Transactions : an International Journal of Inorganic Chemistry
Jie ShenChun-Hua Yan
© 2022 Meta ULC. All rights reserved